South Carolina
CNS clinical trials in South Carolina
62 CNS studies are recruiting participants at sites in 20 cities across South Carolina as of November 16, 2026, according to ClinicalTrials.gov.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Every South Carolina city with a recruiting study
By research area: Depression (25), Parkinson's Disease (15), ADHD (7), Multiple Sclerosis (6), Migraine (5), Epilepsy (2), Schizophrenia (2).
Charleston (43), Greenville (9), North Charleston (8), Anderson (1), Beaufort (1), Bluffton (1), Boiling Springs (1), Columbia (1), Easley (1), Florence (1), Fort Mill (1), Gaffney (1), Georgetown (1), Greer (1), Lancaster (1), Orangeburg (1), Port Royal (1), Rock Hill (1), Seneca (1), Summerville (1).
The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.
Depression: recently updated in South Carolina
Basic details from each study's public record (the 12 most recently updated of 62). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
Behavioral Activation Delivered Via Home-based Telehealth to Improve Functioning in Cardiovascular Disease Patients Recently Discharged From Inpatient Care
- No phase
- Ages 21 and older
- All sexes
- Sponsor
- VA Office of Research and Development
- Recruiting in
- Charleston
- Registry record
- NCT04877197 · updated
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
- Phase 3
- Ages 18 to 74
- All sexes
- Sponsor
- Definium Therapeutics US, Inc.
- Recruiting in
- North Charleston
- Registry record
- NCT07592689 · updated
Source: ClinicalTrials.gov. Data processed . See every depression study recruiting in South Carolina on ClinicalTrials.gov.
Schizophrenia: recently updated in South Carolina
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
- Phase 2
- Ages 55 to 90
- All sexes
- Sponsor
- MapLight Therapeutics
- Recruiting in
- Port Royal
- Registry record
- NCT06887192 · updated
Source: ClinicalTrials.gov. Data processed . See every schizophrenia study recruiting in South Carolina on ClinicalTrials.gov.
ADHD: recently updated in South Carolina
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-2)
- Phase 3
- Ages 6 to 11
- All sexes
- Sponsor
- Axsome Therapeutics, Inc.
- Recruiting in
- North Charleston
- Registry record
- NCT07717879 · updated
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-3)
- Phase 3
- Ages 12 to 17
- All sexes
- Sponsor
- Axsome Therapeutics, Inc.
- Recruiting in
- North Charleston
- Registry record
- NCT07717892 · updated
Source: ClinicalTrials.gov. Data processed . See every ADHD study recruiting in South Carolina on ClinicalTrials.gov.
Parkinson's disease: recently updated in South Carolina
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
- Phase 3
- Ages 18 and older
- Female participants
- Sponsor
- AstraZeneca
- Recruiting in
- Charleston
- Registry record
- NCT06989112 · updated
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Recruiting in
- Charleston · Greenville
- Registry record
- NCT06966700 · updated
Accelerated rTMS for Apathy in Parkinson's Disease
- No phase
- Ages 45 to 85
- All sexes
- Sponsor
- Medical University of South Carolina
- Recruiting in
- Charleston
- Registry record
- NCT07399496 · updated
Source: ClinicalTrials.gov. Data processed . See every Parkinson's disease study recruiting in South Carolina on ClinicalTrials.gov.
Multiple sclerosis (MS): recently updated in South Carolina
A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
- Phase 3
- Ages 18 to 60
- All sexes
- Sponsor
- Zenas BioPharma (USA), LLC
- Recruiting in
- Greenville
- Registry record
- NCT07299019 · updated
A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
- Phase 3
- Ages 18 to 60
- All sexes
- Sponsor
- Zenas BioPharma (USA), LLC
- Recruiting in
- Greenville
- Registry record
- NCT07067463 · updated
Source: ClinicalTrials.gov. Data processed . See every multiple sclerosis study recruiting in South Carolina on ClinicalTrials.gov.
Migraine: recently updated in South Carolina
Study of EVO756 in Adults With Migraine
- Phase 2
- Ages 18 to 64
- All sexes
- Sponsor
- Evommune, Inc.
- Recruiting in
- Charleston
- Registry record
- NCT07616128 · updated
A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- Phase 3
- Ages 18 to 75
- All sexes
- Sponsor
- TriGemX Bio, Inc.
- Recruiting in
- Anderson · Gaffney
- Registry record
- NCT07816367 · updated
Source: ClinicalTrials.gov. Data processed . See every migraine study recruiting in South Carolina on ClinicalTrials.gov.
Ask about studies in South Carolina
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.
CNS Clinical Research does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections